The effect of high dose simvastatin on, platelet size in patients with, type 2 diabetes mellitus

Platelets

Volumn 17, Issue 5, 2006, Pages 292-295

  Isley, William L ^a   Park, Youngsoon ^b   Harris, William S ^c  

^a MAYO CLINIC   (United States)

^b Hanyang University   (South Korea)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Coagulation; Platelets; Simvastatin; Type 2 diabetes

Indexed keywords

COLLAGEN; PLACEBO; SIMVASTATIN;

ADULT; ARTICLE; CELL SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD EXPOSURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME;

BLOOD PLATELETS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLATELET ACTIVATION; SIMVASTATIN; SINGLE-BLIND METHOD;

EID: 33747795963     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100600746490     Document Type: Article

References (29)

1. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004;164(13):1427-1436.
2. McFarlane SI, Muniyappa R, Francisco R, Sowers JR. Clinical review 145: Pleiotropic effects of statins: Lipid reduction and beyond. J Clin Endocrinol Metab 2002;87(4):1451-1458.
3. Balk EM, Lau J, Goudas LC, Jordan HS, Kupelnick B, Kim LU et al. Effects of statins on nonlipid serum markers associated with cardiovascular disease: A systematic review. Ann Intern Med 2003;139(8):670-682.
4. Erusalimsky JD, Martin JF. The regulation of megakaryocyte polyploidization and its implications for coronary artery occlusion. Eur J Clin Invest 1993;23(1):1-9.
5. Cameron HA, Phillips R, Ibbotson RM, Carson PH. Platelet size in myocardial infarction. Br Med J (Clin Res Ed) 1983;287(6390):449-451.
6. Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35(3):622-626.
7. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993;86(11):739-742.
8. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002;13(5-6):301-306.
9. Harfenist E, Murray R. Plasma proteins, immunoglobulins, and blood coagulation. In: Murray R, Granner D, Mayes P, Rodwell V, editors. Harper's biochemistry. 23rd ed. Norwalk, CT: Appelton & Lange; 1993. pp. 665-687.
10. Laufer N, Grover NB, Ben-Sasson S, Freund H. Effects of adenosine diphosphate, colchicine and temperature on size of human platelets. Thromb Haemost 1979;41(3):491-497.
11. Borst C, Bos AN, Zwaginga JJ, Rienks R, de Groot PG, Sixma JJ. Loss of blood platelet adhesion after heating native and cultured human subendothelium to 100 degrees Celcius. Cardiovasc Res 1990;24(8):665-668.
12. Martin JF, Plumb J, Kilbey RS, Kishk YT. Changes in volume and density of platelets in myocardial infarction. Br Med J (Clin Res Ed) 1983;287(6390):456- 459.
13. Isley WL, Miles JM, Patterson BW, Harris WS. The effect of high dose simvastatin on very low density lipoprotein metabolism in patients with type 2 diabetes mellitus. J Lipid Res 2006;1(1):1-8.
14. Beigel Y, Fuchs J, Snir M, Green P, Lurie Y, Djaldetti M. Lovastatin therapy in hypercholesterolemia: Effect on fibrinogen, hemorrheologic parameters, platelet activity, and red blood cell morphology. J Clin Pharmacol 1991;31(6):512-517.
15. Notarbartolo A, Davi G, Averna M, Barbagallo CM, Ganci A, Giammarresi C et al. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995;15(2):247-251.
16. Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract 1988;5(1):63-69.
17. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338(8780):1409-1411.
18. McGill DA, Ardlie NG. Abnormal platelet reactivity in men with premature coronary heart disease. Coron Artery Dis 1994;5(11):889-900.
19. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998;19(1):80-84.
20. Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD. Platelet reactivity in acute coronary syndromes: Evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 2001;85(6):989-994.
21. Li D, Turner A, Sinclair AJ. Relationship between platelet phospholipid FA and mean platelet volume in healthy men. Lipids 2002;37(9):901-906.
22. Mezzano D, Kosiel K, Martinez C, Cuevas A, Panes O, Aranda E et al. Cardiovascular risk factors in vegetarians. Normalization of hyperhomocysteinemia with vitamin B(12) and reduction of platelet aggregation with n-3 fatty acids. Thromb Res 2000;100(3):153-160.
23. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet 1990;336(8708):129-133.
24. Smith NM, Pathansali R, Bath PMW. Altered megakaryocyte-platelet- haemostatic axis in patients with acute stroke. Platelets 2002;13:113-120.
25. Pathansali R, Smith NM, Bath PMW. Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: A pilot study. Platelets 2001;12:144-149.
26. de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. Am Med Assoc 2004;292(11):1307-1316.
27. Nissen SE. High-dose statins in acute coronary syndromes: Not just lipid levels. J Am Med Assoc 2004;292(11):1365-1367.
28. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1(9):1897-1905.
29. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New Engl J Med 2004;350(15):1495-1504.